Expanded Availability of Intravenous Artesunate for the Treatment of Severe Malaria in the United States

Am J Trop Med Hyg. 2019 Jun;100(6):1295-1296. doi: 10.4269/ajtmh.19-0230.

Authors

Philip J Rosenthal¹, Kathrine R Tan²

Affiliations

¹ Department of Medicine, University of California, San Francisco, California.
² Malaria Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.

No abstract available

Publication types

Editorial

MeSH terms

Administration, Intravenous
Antimalarials / supply & distribution*
Antimalarials / therapeutic use
Artesunate / supply & distribution*
Artesunate / therapeutic use
Centers for Disease Control and Prevention, U.S. / legislation & jurisprudence
Drug Administration Schedule
Drug Approval*
Humans
Malaria, Falciparum / drug therapy*
Malaria, Falciparum / epidemiology
Quinidine / therapeutic use
Quinine / therapeutic use
United States / epidemiology
United States Food and Drug Administration / legislation & jurisprudence

Substances

Antimalarials
Artesunate
Quinine
Quinidine